Changes in hair morphology of mucopolysaccharidosis I patients treated with recombinant human α-L-iduronidase (laronidase, aldurazyme)

American Journal of Medical Genetics

Volumn 139 A, Issue 3, 2005, Pages 199-203

  Kloska, Anna ^a   Bohdanowicz, Jerzy ^a   Konopa, Grazyna ^a   Tylki Szymńska, Anna ^b   Jakóbklewicz Banecka, Joanna ^c   Czartoryska, Barbara ^d   Liberek, Anna ^e   Wecedil, Alicja ^c   Wȩgrzyn, Grzegorz ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^d INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^e MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Enzyme replacement therapy; Hair morphology; Mucopolysaccharidosis type I

Indexed keywords

DERMATAN SULFATE; HEPARAN SULFATE; LARONIDASE; LEVO IDURONIDASE;

ADOLESCENT; ARTICLE; CASE REPORT; DIAGNOSTIC VALUE; DRUG EFFICACY; ENZYME DEFICIENCY; FEMALE; GENETIC DISORDER; GLYCOSAMINOGLYCAN METABOLISM; HAIR ANALYSIS; HAIR DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METABOLIC DISORDER; MUCOPOLYSACCHARIDOSIS; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; RARE DISEASE; SCHOOL CHILD;

ADOLESCENT; CHILD; FEMALE; GLYCOSAMINOGLYCANS; HAIR; HUMANS; IDURONIDASE; MALE; MICROSCOPY, ELECTRON, SCANNING; MUCOPOLYSACCHARIDOSIS I; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 28444435927     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.31021     Document Type: Article

References (12)

1. Hall CW, Neufeld EF. 1973. α-L-iduronidaze activity in cultured skin fibroblasts and amniotic fluid cells. Arch Biochem Biophys 158:817-821.
2. Hinek A, Wilson SE. 2000. Impaired elastogenesis in Hurler disease: Dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly. Am J Pathol 156:925-938.
3. Hopwood JJ, Morris CP. 1990. The mucopolysaccharidoses: Diagnosis, molecular genetics and treatment. Mol Biol Med 7:381-404.
4. Kakavanos R, Turner CT, Hopwood JJ, Kakkis ED, Brooks DA. 2003. Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I. Lancet 361:1608-1613.
5. Kakkis ED. 2002. Enzyme replacement therapy for the mucopolysaccharide storage disorders. Expert Opin Investig Drugs 11:675-685.
6. Kakkis ED, Muenzer J, Tiller GE, Waber L, Belmont J, Passage M, Izykowski B, Philips J, Doroshow R, Walot I, Hoft R, Neufeld EF. 2001. Enzyme-replacement therapy in mucopolysaccharidosis I. New Eng J Med 344:182-188.
7. Neufeld EF, Muenzer J. 2001. The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill Co. p 3421-3452.
8. Pennock CA. 1976. A review and selection of simple laboratory methods used for the study of glycosaminoglycan excretion and the diagnosis of mucopolysaccharidoses. J Clin Pathol 29:111-123.
9. Roubicek M, Gehler J, Spranger J. 1985. The clinical spectrum of α-L-iduronidase deficiency. Am J Med Genet 20:471-481.
10. Wȩgrzyn G, Wȩgrzyn A, Tylki-Szymańska A. 2004. A general model for genetic regulation of turnover of glycosaminoglycans suggests a possible procedure for prediction of severity and clinical progress of mucopolysaccharidoses. Med Hypoth 62:986-992.
11. Wraith JE. 2001. Enzyme replacement therapy in mucopolysacchariodosis type I: Progress and emerging difficulties. J Inherit Metab Dis 24:245-250.
12. Wraith JE, Clarke LA, Beck M, Kolodny EH, Pastores GM, Muenzer J, Rapoport DM, Berger KI, Swiedler SJ, Kakkis ED, Braakman T, Chadbourne E, Walton-Bowen K, Cox GF. 2004. Enzyme replacement therapy for mucopolysaccharidosis I: A randomized, double-blinded, placebo-controlled, multinational study of recombinant human α-L-iduronidase (Laronidase). J Pediatr 144:581-588.